Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed with results

Key Signals

4 with results91% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (2)
P 1 (1)
P 2 (2)
P 3 (2)
P 4 (2)

Trial Status

Completed10
Recruiting1
Terminated1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (12)

Research Network

Activity Timeline